Skip to main content
SpringerLink
Log in

CRC in Remission: Monitoring mit 18FDG-PET/CT lohnt sich nicht

  • Gastroonkologie
  • Literatur kompakt
  • Published:
Im Focus Onkologie Aims and scope

Die 18FDG-PET/CT hat eine hohe Sensitivität bei der Detektion von Rezidiven eines kolorektalen Karzinoms. Allerdings verursacht sie hohe Kosten, ohne dass die Patienten davon profitieren.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Judith Neumaier

Authors
  1. Judith Neumaier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Neumaier, J. CRC in Remission: Monitoring mit 18FDG-PET/CT lohnt sich nicht. Im Focus Onkologie 21, 24–26 (2018). https://doi.org/10.1007/s15015-018-4150-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-018-4150-4

Search

Navigation